Insider Trading Activity For Genesis HealthCare (NYSE:GEN)
Paul David Bach , COO of Genesis HealthCare (NYSE:GEN) reportedly Sold 10,131 shares of the company’s stock at an average price of 2.19 for a total transaction amount of $22,186.89 SEC Form
Insider Trading History For Genesis HealthCare (NYSE:GEN)
Analyst Ratings History For Genesis HealthCare (NYSE:GEN)
- On 8/22/2016 UBS Group Reiterated Rating Sell
- On 9/19/2016 Bank of America Set Price Target of rating Sell with a price target of $1.80
- On 7/5/2017 Cantor Fitzgerald Initiated Coverage of rating Overweight
- On 9/13/2017 Royal Bank of Canada Reiterated Rating Hold with a price target of $2.00
- On 3/19/2018 Stephens Reiterated Rating Hold with a price target of $2.00
- On 4/24/2018 Stifel Nicolaus Set Price Target of rating Hold with a price target of $2.00
Recent Trading Activity for Genesis HealthCare (NYSE:GEN)
Shares of Genesis HealthCare closed the previous trading session at 2.38 +0.00 0.00% with 2.2100000381469727 shares trading hands.